We used the drug avelox, a new fluoroquinolone of the fourth generation, in therapy of urogenital infections (caused by chlamydia, mycoplasma, ureaplasma) in men. The test group consisted of 45 men with urethritis, urethroprostatitis given avelox in a single dose of 400 mg/day for 10 days. 18 control patients with urethritis took ofloxacin in a dose of 200 mg twice a day for 10 days. Examination for infection eradication was made 2 weeks and 2 months after the end of the treatment. Eradication of chlamydial infection was achieved in 18 (94.73%) patients, mycoplasma (ones in 23 (80%), ureaplasma--in 29 (86%) patients. Thus, clinical efficiency of avelox may be characterized as very good in chlamydial infection, good in ureaplasma and mycoplasma infections. Side effects occurred only in 5 patients who had short-term transient gastrointestinal disorder. Compared to ofloxacin, avelox is more effective and less toxic.
Download full-text PDF |
Source |
---|
PeerJ
January 2025
Center of Reproductive Medicine, Qingdao Women and Children's Hospital, Qingdao, China.
Background: Group B streptococcus (GBS) colonization in pregnant women is associated with adverse perinatal outcomes, including stillbirth. This meta-analysis investigated the relationship between maternal rectovaginal GBS colonization and the risk of stillbirth.
Methods: We conducted a comprehensive literature search across several databases, including PubMed, Embase, Web of Science, Wanfang, and China National Knowledge Infrastructure, covering studies published from the inception of the database until September 9, 2024.
World J Urol
January 2025
Department of Urology, Hospital of Vall Hebron, Autonomous University of Barcelona, Barcelona, Spain.
Introduction: Open ureteroenteric reimplantation (OUER) of ureteroenteric strictures (UESs) is related to important morbidity. Robot-assisted ureteroenteric reimplantation (RUER) has been proposed to provide similar outcomes with lower morbidity. We aimed to compare perioperative and functional outcomes between RUER and OUER.
View Article and Find Full Text PDFCureus
December 2024
Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, SAU.
Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for type 2 diabetes mellitus (T2DM). The effect and tolerability of SGLT2 inhibitors in patients with T2DM, especially related risk factors and susceptible populations, are an area of ongoing research. Aim The aim of this study was to evaluate the tolerability of SGLT2 inhibitors, particularly the risk associated with urogenital infection, in patients with T2DM.
View Article and Find Full Text PDFInfect Drug Resist
January 2025
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Monkeypox (mpox), caused by mpox virus (MPXV) infection, reemerged in 2022 and still raises concerns globally. Abundant clinical data indicate that mpox is a sexually transmitted infection and that the urogenital system is the most frequently involved system in mpox, which deserves more attention. Penile lesions are the most common presentation, followed by urethritis.
View Article and Find Full Text PDFSci Rep
January 2025
Faculty of Veterinary Medicine, University of Khartoum, Khartoum, Sudan.
Schistosomiasis poses a significant global health threat, particularly in tropical and subtropical regions like Sudan. Although numerous epidemiological studies have examined schistosomiasis in Sudan, the genetic diversity of Schistosoma haematobium populations, specifically through analysis of the mtcox1 gene, remains unexplored. This study aimed to investigate the risk factors associated with urogenital schistosomiasis among school pupils in El-Fasher, Western Sudan, as well as the mtcox1 genetic diversity of human S.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!